Congress appropriated $1.1 billion—the total worth of 1,100 millionaires—to “comparative effectiveness research” (CER). It promised that CER would not turn out to be “cost-effectiveness research”—and the rationale for treatment rationing and denial—although it defeated a proposed amendment that would have codified that promise into law. Continue reading →